After more and more evidence emerged, that cardiovascular diseases (CVDs) such as ischemic stroke and acute myocardial infarction are related to inflammation (Libby et al., 2002), moderately elevated levels of CRP, so called high-sensitive CRP (hs-CRP), gained interest as a potential new biomarker for these diseases. Here, CRP is linked to ischemic stroke.